Related Experiment Video
Updated: Jul 17, 2026
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
[PSA doubling time as a new diagnostic and prognostic method for prostate cancer]
Carlos Llorente1, José Manuel de la Morena, Manuel Alvarez Ardura
1Servicio de Urología, Fundacion Hospital Alcorcón, Profesor Asociado de Cirugía Universidad Rey Juan Carlos, Madrid, España. cllorente@fhalcorcon.es
Objectives:
To review the value of PSA kinetics in the diagnosis and prognosis of prostate cancer.
Methods:
Review of the literature through a Medline search.
Conclusions:
A pre-tretament PSAV value >2ng/ ml/yr is a risk factor for increased mortality from prostate cancer after surgery or radiation therapy. A PSADT<3ms is indicative of reduced survival after treatment. For patients with PSA recurrence after surgery a PSADT> 10 is more likely associated with local recurrence.
